TickerKhojComparison · NSE · data 2026-11-03
Sanofi Consumer Healthcare India Limited vs Symbiotec Pharmalab Limited
In plain words
Size: Symbiotec Pharmalab Limited is about 1 times the market value of Sanofi Consumer Healthcare India Limited.
Differences in the numbers, not a recommendation of either stock.
Side by side
| SANOFICONR | SYMBIOTEC | |
|---|---|---|
| Price | ₹3,520.2 | ₹1,225 |
| Market cap | ₹7,911 cr | ₹8,001 cr |
| P/E | 29 | — |
| P/B | — | — |
| ROE | 73.1% | — |
| ROCE | 82.8% | — |
| Debt / equity | 0.06 | — |
| Operating margin | 36.4% | — |
| Dividend yield | 2.18% | 0.00% |
| Sales growth, 3 years (yearly) | — | — |
| Profit growth, 3 years (yearly) | — | — |
| 1-year return | -24.3% | 24.0% |
| Revenue, last 12 months | ₹979 cr | — |
| Net profit, last 12 months | ₹280 cr | — |
| Latest quarter | Sept 2026 | Jun 2026 |
| Quarter net profit | ₹77 cr | ₹14 cr |
| Quarter profit vs a year earlier | +21.8% | — |
| Promoter holding | 71.27% | 33.28% |
| Health check | Strong (7/10) | Strong (8.2/10) |